Ryuki Matsumoto

Mie University

Papers

1

Total Citations

5

H-Index

1

About

Ryuki Matsumoto is a leading urological oncologist whose research centers on prostate cancer risk stratification, surgical outcomes, and the interplay between genetic predisposition and disease progression in Japanese populations. His most cited work, a 2022 study examining the impact of family history on clinicopathological variables in patients undergoing robotic-assisted radical prostatectomy, has garnered 5 citations and provides critical insights into how first-degree family history correlates with disease severity and progression in localized prostate cancer. By analyzing a cohort of 392 consecutive patients, Matsumoto demonstrated that familial cases exhibit distinct clinical features, informing personalized screening and treatment strategies. His contributions extend to refining surgical techniques and prognostic models, bridging the gap between genetic epidemiology and precision oncology. With a growing citation footprint, Matsumoto’s work is shaping guidelines for Asian men, where prostate cancer incidence is rising. His research not only advances understanding of hereditary risk factors but also underscores the value of tailored interventions in robotic surgery, making him a pivotal figure in urologic oncology and a resource for clinicians and researchers seeking to improve outcomes through integrated genetic and surgical approaches.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Impact of family history on clinicopathological variables and disease progression in Japanese prostate cancer patients undergoing robotic‐assisted radical prostatectomy
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Mie University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago